Table 5.
In vitro and in vivo assays for bioimaging of Ag-based QDs.
| Type of QDs | Cell Line/Organism | Fluorescence (nm) | Route of Administration |
Reference |
|---|---|---|---|---|
| Ag2S | Mouse fibroblast L929 cell line | 1100–1700 | Cells were fixed in 4% paraformaldehyde and treated with QDs (in vitro studies) | [91] |
| Human malignant glioma U87 MG cell line | ||||
| Human breast cancer MDA-MB-468 cell line (ATCC) | ||||
| Ag2Se | Male CD-1 (ICR) mice | 700–820 | Intravenous injection (in vivo studies) | [93] |
| Ag2Te | Male ICR mice | 900–1300 | Intravenous injection (in vivo studies) | [94] |
| AgInS2 | Radiation induced fibrosarcoma (RIF) cells | 800 | Intravenous injection (in vivo studies) | [88] |
| Human peripheral blood monocyte-derived macrophages (MDM) | ||||
| AgInS2/ZnS | Human hepatoma cell line (Hep G2) | 500–700 | QDs delivered into Hep G2 cells and specifically combined with antigens (in vitro studies) | [95] |